1-4 of 4
Dan Jones
Close
Sort by
Journal Articles

Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories

Clinical Trials & Observations
Uma Borate, Fei Yang, Richard Press, Amy S. Ruppert, Dan Jones, Sean Caruthers, Weiqiang Zhao, Jo-Anne Vergilio, Dean C. Pavlick, Luke Juckett, Brianna Norris, Taylor Bucy, Amy Burd, Eytan M. Stein, Prapti Patel, Maria R. Baer, Wendy Stock, Gary Schiller, William Blum, Tibor Kovacsovics, Mark Litzow, James Foran, Nyla A. Heerema, Leonard Rosenberg, Sonja Marcus, Ashley Yocum, Mona Stefanos, Brian Druker, John C. Byrd, Ross L. Levine, Alice Mims
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6048–6054.
https://doi.org/10.1182/bloodadvances.2022009008
Published: 2023
Includes: Supplemental data
Journal Articles

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes

Clinical Trials & Observations
Jonathan M. Hyak, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, John C. Byrd, Adam S. Kittai, Dan Jones, Cecelia R. Miller, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5124–5127.
https://doi.org/10.1182/bloodadvances.2022007708
Published: 2022
Includes: Supplemental data
Journal Articles

Midostaurin in patients with acute myeloid leukemia and FLT3 -TKD mutations: a subanalysis from the RATIFY trial

Clinical Trials & Observations
Maria Teresa Voso, Richard A. Larson, Dan Jones, Guido Marcucci, Thomas Prior, Jürgen Krauter, Michael Heuser, Serena Lavorgna, Josep Nomdedeu, Susan M. Geyer, Alison Walker, Andrew H. Wei, Jorge Sierra, Miguel A. Sanz, Joseph M. Brandwein, Theo M. de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Sergio Amadori, Yuan Cheng, YinMiao Chen, Celine Pallaud, Ling Du, Alfonso Piciocchi, Gerhard Ehninger, John Byrd, Christian Thiede, Konstanze Döhner, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield, Francesco Lo-Coco
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4945–4954.
https://doi.org/10.1182/bloodadvances.2020002904
Published: 2020
Includes: Supplemental data
Journal Articles

Resistance mechanism for ibrutinib in marginal zone lymphoma

Clinical Trials & Observations
Narendranath Epperla, Arwa Y. Shana’ah, Dan Jones, Beth A. Christian, Sabarish Ayyappan, Kami Maddocks, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2019) 3 (4): 500–502.
https://doi.org/10.1182/bloodadvances.2018029058
Published: 2019
Includes: Supplemental data